(NYSE: CNC) Centene's forecast annual revenue growth rate of -0.62% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Centene's revenue in 2024 is $153,999,000,000.On average, 7 Wall Street analysts forecast CNC's revenue for 2024 to be $78,172,104,819,130, with the lowest CNC revenue forecast at $76,886,756,823,625, and the highest CNC revenue forecast at $79,610,399,563,800. On average, 7 Wall Street analysts forecast CNC's revenue for 2025 to be $81,146,699,930,275, with the lowest CNC revenue forecast at $79,696,084,616,400, and the highest CNC revenue forecast at $83,232,545,286,100.
In 2026, CNC is forecast to generate $84,869,100,908,158 in revenue, with the lowest revenue forecast at $84,038,690,799,700 and the highest revenue forecast at $86,145,302,211,500.